These results suggest that the enhanced glycolysis in RA-cTfh cells is related to CXCL13-CXCR5 signaling, while the increased mtROS in RA-Tph cells is related to CCL2-CCR2 signaling. The gene discussed is CCL2; the disease is rheumatoid arthritis.